We are live on
!
Find out more
UOC
UBS O'Connor Portfolio holdings
AUM
$3.38B
1-Year Est. Return
63.08%
This Fund
S&P 500
This Quarter
Est. Return
+9.09%
1 Year Est. Return
+63.08%
3 Year Est. Return
+180.99%
5 Year Est. Return
+483.22%
10 Year Est. Return
+2,128.62%
AUM
$5.62B
AUM Growth
+$874M
(+18%)
Cap. Flow
+$536M
Cap. Flow
% of AUM
9.53%
Top 10 Holdings %
Top 10 Hldgs %
66.07%
Holding
710
New
128
Increased
146
Reduced
103
Closed
149
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
ATVI
Activision Blizzard
ATVI
|
+$779M |
| 2 |
HZNP
Horizon Therapeutics Public Limited Company Ordinary Shares
HZNP
|
+$358M |
| 3 |
NEWR
New Relic, Inc.
NEWR
|
+$258M |
| 4 |
DEN
Denbury Inc.
DEN
|
+$175M |
| 5 |
VMW
VMware, Inc
VMW
|
+$165M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
ISEE
IVERIC bio, Inc. Common Stock
ISEE
|
+$230M |
| 2 |
PDCE
PDC Energy, Inc.
PDCE
|
+$221M |
| 3 |
UNVR
Univar Solutions Inc.
UNVR
|
+$219M |
| 4 |
FOCS
Focus Financial Partners Inc. Class A
FOCS
|
+$146M |
| 5 |
SYNH
Syneos Health, Inc. Class A Common Stock
SYNH
|
+$141M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 34.82% |
| 2 | Healthcare | 28.77% |
| 3 | Real Estate | 5.15% |
| 4 | Financials | 4.39% |
| 5 | Consumer Discretionary | 4.35% |
Similar funds
FNBT
SAG
ACI
RC
A
CGL
CB
JCM
UBS O'Connor's Q3 2023 Portfolio in Review
As of Q3 2023, UBS O'Connor held 710 positions worth $5.62B, up 18% from $4.75B the previous quarter. Its ten largest holdings account for 66% of the portfolio.
UBS O'Connor deployed $536M of net new capital in Q3 2023, opening 128 new positions and adding to 146 existing holdings. Its largest new stake was Denbury Inc.: 1,931,731 shares worth $189M.
By sector, the portfolio is most concentrated in Technology at 35% of assets, up from 16% a quarter earlier, followed by Healthcare and Real Estate.
On the sell side, the largest reduction was Seagen Inc. Common Stock, an estimated $19.7M trimmed.
- UBS O'Connor's largest Q3 2023 buy was Denbury Inc.: 1,931,731 shares worth $189M.
- UBS O'Connor added most to Activision Blizzard in Q3 2023, an estimated $779M increase.
- UBS O'Connor's biggest Q3 2023 reduction was Seagen Inc. Common Stock, cutting an estimated $19.7M.
- UBS O'Connor fully exited IVERIC bio, Inc. Common Stock in Q3 2023, selling an estimated $230M.
- UBS O'Connor's ten largest holdings make up 66% of its $5.62B portfolio in Q3 2023.
- UBS O'Connor opened 128 new positions and closed 149 in Q3 2023.
- UBS O'Connor's portfolio value rose 18% quarter-over-quarter to $5.62B.
Based on UBS O'Connor's 13F filing for Q3 2023, filed 14 Nov 2023.